57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65

At least two in five U.S. adults — more than 57 million people - under the age of 65 with "private insurance could be eligible for GLP-1 drugs," a new KFF analysis shows.